Kenneth Michael Reali insider trades: Bioventus (BVS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | BVS | ↓ Sell | 9,811 | $1.39 | $14K | Direct | Mar 16, 2023 (1d) |
| Sep 9, 2021 | BVS | ↑ Buy | 1,800 | $14.81 | $27K | Direct | Sep 10, 2021 (1d) |
| Feb 11, 2021 | BVS | ↑ Buy | 9,375 | $13.00 | $122K | Direct | Apr 5, 2021 (53d) |
| Aug 15, 2014 | BAXS | ↑ Buy | 10,000 | $0.38 | $4K | Direct | Aug 19, 2014 (4d) |
| May 12, 2014 | BAXS | ↑ Buy | 7,050 | $0.71 | $5K | Direct | May 14, 2014 (2d) |
| Dec 5, 2013 | BAXS | ↑ Buy | 10,500 | $1.11 | $12K | Direct | Dec 6, 2013 (1d) |
| Jun 7, 2012 | TSON | ↑ Buy | 7,000 | $2.57 | $18K | Direct | Jun 11, 2012 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BVS insiders
Open-market trades in the last 12 months
About Kenneth Michael Reali's insider trades
Kenneth Michael Reali is Chief Executive Officer at Bioventus (BVS). Since Jun 7, 2012, Kenneth has reported 6 open-market purchases worth $187K and 1 sale worth $14K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.